Education
About Us
Working with TipRanks
Follow Us
BBIN - ETF AI Analysis
Top Page
JPMorgan BetaBuilders International Equity ETF (BBIN)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key positions, such as ASML Holding and Nestlé, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF has a very low expense ratio, making it cost-effective compared to many other funds.
Broad Geographic Exposure
The fund is diversified across multiple countries, reducing reliance on any single economy.
Negative Factors
Underperforming Holdings
Some top holdings, like SAP and Toyota Motor, have lagged in performance, which could weigh on future returns.
Sector Concentration in Financials
The ETF has heavy exposure to the financial sector, increasing vulnerability to sector-specific risks.
Limited U.S. Exposure
With only a small allocation to U.S. companies, the fund may miss out on opportunities in the world's largest economy.
BBIN vs. SPDR S&P 500 ETF (SPY)
AUM6.04B
RegionDeveloped Markets
Expense Ratio0.07%
Beta0.71
IssuerJPMorgan
Inception DateDec 03, 2019
Dividend Yield2.8%
Asset ClassEquity
Index TrackedMorningstar Developed Markets ex-North America Target Market Exposure Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume95,179
30 Day Avg. Volume189,167
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
80.43Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering672
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BBIN Summary
The JPMorgan BetaBuilders International Equity ETF (BBIN) is an investment fund that focuses on international companies outside North America, following the Morningstar Developed Markets ex-North America Target Market Exposure Index. It includes well-known companies like Nestlé and Toyota, and spans industries such as finance, healthcare, and technology. This ETF is a great option for investors looking to diversify their portfolios globally and gain exposure to markets in countries like Japan, the UK, and Germany. However, new investors should be aware that its performance can be impacted by fluctuations in international markets and currency exchange rates.
How much will it cost me?The JPMorgan BetaBuilders International Equity ETF (BBIN) has an expense ratio of 0.07%, meaning you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically has lower costs than actively managed funds.
What would affect this ETF?Positive drivers for BBIN could include economic growth in developed markets outside North America, which may boost the performance of its top holdings like ASML, Nestlé, and Toyota. However, negative factors such as rising interest rates or geopolitical tensions in Europe or Asia could impact sectors like Financials and Industrials, which have significant weight in the ETF. Additionally, regulatory changes in these regions could affect the profitability of key companies in the portfolio.
BBIN Top 10 Holdings
The JPMorgan BetaBuilders International Equity ETF (BBIN) leans heavily on developed markets outside North America, with a notable focus on financials and industrials. Roche Holding AG and AstraZeneca are rising stars, buoyed by strong pipelines and robust earnings, while Nestlé provides steady support with its reliable cash flow. However, SAP SE has been lagging, weighed down by bearish momentum and valuation concerns, which could be a drag on the fund’s performance. Overall, BBIN offers a balanced approach to international equities, but its sector concentration may leave it vulnerable to shifts in financial and industrial markets.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.21% | $133.82M | €353.45B | 35.81% | 76 Outperform | |
| AstraZeneca | 1.41% | $85.14M | £208.42B | 27.75% | 80 Outperform | |
| Roche Holding AG | 1.38% | $83.76M | CHF253.28B | 42.40% | 73 Outperform | |
| HSBC Holdings | 1.31% | $79.44M | HK$1.99T | 46.00% | 80 Outperform | |
| SAP SE | 1.28% | $77.31M | €242.99B | -12.57% | 66 Neutral | |
| Nestlé SA | 1.26% | $76.41M | CHF197.01B | 16.44% | 71 Outperform | |
| Novartis AG | 1.23% | $74.56M | CHF200.79B | 20.24% | 80 Outperform | |
| Toyota Motor | 1.17% | $71.02M | ¥42.49T | 24.44% | 80 Outperform | |
| Shell (UK) | 1.07% | $64.53M | £153.44B | 7.52% | 73 Outperform | |
| Siemens | 1.04% | $62.99M | €185.66B | 25.47% | 74 Outperform |
BBIN Technical Analysis
Positive
―
Price Trends
71.28
Positive
70.12
Positive
66.83
Positive
Market Momentum
0.57
Negative
64.60
Neutral
87.69
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BBIN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 71.46, equal to the 50-day MA of 71.28, and equal to the 200-day MA of 66.83, indicating a bullish trend. The MACD of 0.57 indicates Negative momentum. The RSI at 64.60 is Neutral, neither overbought nor oversold. The STOCH value of 87.69 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BBIN.
BBIN Peer Comparison
Comparison Results
Performance Comparison
BBIN
JPMorgan BetaBuilders International Equity ETF
73.47
16.15
28.18%
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
―
―
―
FENI
Fidelity Enhanced International ETF
―
―
―
EFAV
iShares MSCI EAFE Min Vol Factor ETF
―
―
―
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents